CDKN1A and neoplasm: Both MEF2 and p21Cip1(CDKN1A) which unlike MYOD or MYOG are poorly expressed in FN-RMS cells36,37 when activated together with MYOD and MYOG inhibit tumor growth by driving a terminal differentiation program38,39.